Immunoprotein Diagnostic Testing Market Revenue to Attain USD 18.74 Bn by 2033

20 Jun 2025

Share :

Table of Content

1. Immunoprotein Diagnostic Testing Market Revenue and Trends 2025 to 2033 2. Market Overview 3. Segment Outlook 4. Regional Insights 5. Immunoprotein Diagnostic Testing Market Coverage 6. Immunoprotein Diagnostic Testing Market Key Players

Immunoprotein Diagnostic Testing Market Revenue and Trends 2025 to 2033

The global immunoprotein diagnostic testing market revenue reached USD 10.32 billion in 2025 and is predicted to attain around USD 18.74 billion by 2033 with a CAGR of 7.74%. The growth of the market is attributed to the increasing global burden of chronic and infectious diseases, which boosts the demand for early, accurate, and sensitive diagnostic tools.

Market Overview

The immunoprotein diagnostic testing market is experiencing rapid growth, driven by the increasing prevalence of infectious and chronic diseases, including cancer, autoimmune diseases, and cardiovascular diseases. This, in turn, boosts the demand for accurate diagnostic testing. The growing elderly population, who are more prone to developing immune-related diseases, further contributes to market growth. Despite growth potential, the market faces challenges due to high cost of testing and regulatory landscape. Moreover, advances in assay techniques and testing platforms are improving the sensitivity and reducing turnaround times, making testing more efficient.

Segment Outlook

• By test, the immunoglobulin diagnostic tests segment led the market by holding the largest share in 2024. This is due to the increased prevalence of autoimmune and infectious diseases, requiring improved and accurate testing. The increased need for early diagnostics further bolstered the segment.
• By application, the infectious disease testing segment captured the biggest market share in 2024 due to the high adoption of immunoprotein diagnostic testing in public diagnostic programs as a result of the growing concerns over outbreaks. This testing provides accurate insights into the development and symptoms of infectious diseases.
• By technology, the enzyme-based immunoassays segment dominated the market in 2024. This is mainly due to their increased usage in diagnostics, research, and drug testing for their high sensitivity.
• By distribution channel, the retail sales segment led the market in 2024 due to the expanding pharmacy chain and ease of acquisition through pharmacies. They often provide guidance regarding the applications, enhancing patient satisfaction and increasing sales.
• By end-user, the hospitals & clinics segment contributed a major market share in 2024 as these settings are a primary care destination, leading to increased patient volume. As patient volume increases in these settings, so does the need for diagnostic testing, bolstering segmental growth.

Regional Insights

North America held the largest share of the immunoprotein diagnostic testing market in 2024 due to its advanced healthcare infrastructure, significant R&D investment, a large geriatric demographic, and high chronic disease rates. High healthcare spending in countries like the U.S. and Canada boosts the demand for diagnostic tools, including immunoprotein testing.

Asia Pacific is experiencing the fastest growth due to the increasing prevalence of infectious disease. Rising focus on early disease detection further boosts the demand for immunoprotein testing.

Immunoprotein Diagnostic Testing Market Coverage

Recent Development

• In June 2024, Sysmex Corporation announced a plan to launch HISCL VEGF Assay Kit and HISCL PEDF Assay Kit for research use in Japan. These kits measure secreted proteins in cell culture media in regenerative cellular medicine.
  (Sources: https://www.biospace.com)

Immunoprotein Diagnostic Testing Market Key Players

• Agilent Technologies, Inc.
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories, Inc.
• Aurora Biomed Inc.
• Tecan Trading AG
• Promega Corporation
• Charles River Laboratories
• Creative Biolabs

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6259

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com|+1 804 441 9344